We are pleased to announce that Dr. Zanos, Director of the Translational Neuropharmacology Lab, has been appointed as an Editorial Board Member of Neuropharmacology, one of the leading journals in the field of neuroscience and pharmacology.

Neuropharmacology, published by Elsevier, is a premier international journal that publishes high-impact research on the effects of drugs on the nervous system. The journal covers a broad range of topics including molecular, cellular, and behavioral neuropharmacology, making it an essential publication for researchers advancing our understanding of brain function and therapeutics.

As an Editorial Board Member, Dr. Zanos will contribute to the peer review process and help shape the direction of neuropharmacology research by evaluating cutting-edge manuscripts in his areas of expertise. This appointment recognizes Dr. Zanos’s significant contributions to the field and his standing as a leader in translational neuropharmacology research.

This role will further strengthen our lab’s connections to the broader scientific community and enhance our engagement with the latest developments in neuropharmacology.